• Cycle Pharmaceuticals secures $25m debt financing pharmaceutical-business-review
    September 23, 2020
    Cycle Pharmaceuticals, a privately-owned, global, patient-dedicated biotechnology company focused on developing and delivering medicines for rare diseases, announced that it has executed a definitive agreement for a $25 million credit facility with ...
PharmaSources Customer Service